S. Korea conditionally approves Danaher's purchase of GE biopharma unit
SEJONG, Feb. 4 (Yonhap) -- South Korea's antitrust regulator said Tuesday it has conditionally approved a deal by U.S. medical equipment maker Danaher to buy General Electric's biopharma unit, after requiring Danaher to sell some assets.
Danaher announced the US$21 billion deal in February last year, which will strengthen its market position in the biopharma industry.
In a statement, Korea's Fair Trade Commission (FTC) said the requirement is necessary because the deal would hurt competition.
The FTC's decision is in line with the European Union's conditional approval for the deal, an FTC official said.
kdh@yna.co.kr
(END)
-
(URGENT) Russian, Chinese warplanes enter S. Korea's air defense zone without notice: JCS
-
BTS to meet Biden at White House to discuss anti-Asian hate crimes
-
Premier League Golden Boot winner Son Heung-min receives hero's welcome home
-
Multiple Russian, Chinese warplanes enter KADIZ without notice: JCS
-
Hyundai Motor to invest US$5 bln in U.S. for robotics, autonomous driving development
-
(5th LD) Yoon, Biden agree to expand joint military exercises to cope with N.K. threats
-
(LEAD) Multiple Russian, Chinese warplanes enter KADIZ without notice: JCS
-
(LEAD) Biden set to arrive in S. Korea for first summit with Yoon
-
With historic Golden Boot, Son Heung-min cements case as greatest S. Korean footballer ever
-
(URGENT) Russian, Chinese warplanes enter S. Korea's air defense zone without notice: JCS
-
BTS to meet Biden at White House to discuss anti-Asian hate crimes
-
(LEAD) Supreme Court rules against peak wage system
-
'The Roundup' becomes most-watched Korean film in pandemic era
-
(LEAD) Yoon picks women for last remaining 2 Cabinet ministers
-
S. Korean volunteer fighter in Ukraine returning home